Show
Sort by
-
- Journal Article
- A1
- open access
In vitro characterization of the pyrazole-carrying synthetic cannabinoid receptor agonist 5F-3,5-AB-PFUPPYCA and its structural analogs
-
- Journal Article
- A1
- open access
Dual-acting small molecules : subtype-selective cannabinoid receptor 2 agonist/butyrylcholinesterase inhibitor hybrids show neuroprotection in an Alzheimer's disease mouse model
-
- Journal Article
- A1
- open access
Off-target activity of NBOMes and NBOMe analogs at the mu opioid receptor
-
Development of an indole-amide-based photoswitchable cannabinoid receptor subtype 1 (CB1R) 'Cis-On' Agonist
-
- Journal Article
- A1
- open access
A new cannabinoid receptor 1 selective agonist evading the 2021 'China ban': ADB‐FUBIATA
-
- Journal Article
- A1
- open access
Cannabinoid receptor activation potential of the next generation, generic ban evading OXIZID synthetic cannabinoid receptor agonists
-
Structure-activity relationships of valine, tert-leucine, and phenylalanine amino acid-derived synthetic cannabinoid receptor agonists related to ADB-BUTINACA, APP-BUTINACA, and ADB-P7AICA
-
NNL-3 : a synthetic intermediate or a new class of hydroxybenzotriazole esters with cannabinoid receptor activity?
-
- Journal Article
- A1
- open access
Assessment of structure-activity relationships and biased agonism at the Mu opioid receptor of novel synthetic opioids using a novel, stable bio-assay platform
-
Hide and seek : overcoming the masking effect of opioid antagonists in activity-based screening tests